The global Biomimetic Technology Market is forecasted to be worth USD 17.73 Billion by 2027, according to a current analysis by Emergen Research. The Biomimetic Technology Market is anticipated to expand exponentially owing to the growing tissue engineering market. The Increasing elderly population would have a significant impact on market growth. The aging population is particularly vulnerable to cardiac, neurosurgery, and orthopedic problems. The rising usage of biomimetics in the cardiac sector will also boost the growth of the biomimetics technology market during the forecast timeline. Besides, the increasing organ failure cases among the geriatric population are expected to propel the demand for this technology shortly.
Key
Highlights From The Report
In October 2020, AeroVironment, Inc. and Viasat Inc.
announced that they would collaborate on a contract awarded under the
Reconfigurable Communications for Small Unmanned Systems initiative of the
United States Army. These two companies will improve the connectivity and
transmission safety of the AeroVironment optical data link radios presently
used by the United States army by transforming these into a video and data
transmission type 1 encrypted communication device.
Over the forecasted timeline, the Molecular Bionics segment
is estimated to hold the largest market wit a CAGR of 10.9% as it is broadly
used in tissue regeneration, molecular genetics, and drug delivery.
The largest market over the forecast period is accounted for
in the drug delivery segment. Market growth is expected to be stimulated by
optimized vaccine production and the specific drug delivery of nanocarriers
through biomimetic devices.
Due to the rising number of prosthetic populations, the
Healthcare segment is forecasted to dominate the forecast timeframe.
Due to the rising investment from government institutions in
different research organizations, the segment of Research Institutes is
expected to experience the fastest market growth.
Due to the rise in R&D and many government initiatives
to introduce advanced solutions, the region of North America is likely to hold
the largest market for biomimetic technology.
Key
participants include Hstar Technologies Corporation, Chas A
Blatchford & Sons Ltd., Applied Biomimetic A/S, SynTouch LLC, Veryan
Medical Ltd., Wright Medical Group, Inc., AeroVironment, Inc., Biohorizons
Implant Systems, Inc, BioMimetic Laboratories, Inc., and Forschungszentrum
Jülich GmbH among others.
Request
for sample report@
Type
Outlook (Revenue, USD Billion; 2017-2027)
Molecular Bionics
Information and Control Bionics
Mechanical Bionics
Energy Bionics
Others
Application
Outlook (Revenue, USD Billion; 2017-2027)
Drug Delivery
Wound Healing
Prosthetics
Tissue Engineering
Surveillance
Rescue
Security and Safety
Underwater Research
Traffic Monitoring
Others
End-Use
Outlook (Revenue, USD Billion; 2017-2027)
Biotechnology
Healthcare
Defense
Research Institutes
Others
Regional Outlook (Revenue, USD Billion;
2017-2027)
North America
Europe
Asia Pacific
Latin America
MEA
No comments:
Post a Comment